Ketek, an antibiotic currently the focus of a congressional investigation for safety issues, is getting a new warning label. The drug’s manufacturer, Sanofi-Aventis added a new warning label noting the risk of liver failure and injury. The label will now have bold text warning that “acute hepatic failure and sever liver injury, in come cases fatal, have been reported in patients treated with Ketek.”
Get rid of any Triaminic Vapor Patches in your medicine cabinet. The Food and Drug Administration (FDA) issued a consumer warning about serious reactions shortly before Novartis Consumer Health recalled the vapor patches.
For years ACE inhibitors, used to treat high blood pressure, have been known to cause birth defects if taken during the last six months of pregnancy. But a new study has found ACE inhibitors pose risks to a fetus even during the first trimester.
Will a mandatory waiting period on ads for prescription drugs and implantable devices give doctors more time to make informed decisions for their patients? According to the American Medical Association (AMA) it will. The nation’s largest doctors group believes a delay of consumer ad campaigns would give doctors the necessary time to study the products.
Manufacturers of prescription cold and allergy medicines containing the antihistamine carbinoxamine were warned by the Food and Drug Administration (FDA) to quit making these products within 90 days because they are not approved by the agency.